In the study performed by Blaszak et al., 70% higher chemerin concentration was observed in chronic kidney disease (CKD) patients compared to the control group (p < .001) and also elevated serum chemerin concentration in CKD patients was correlated to kidney function and hemodialysis treatment [16]. Here, RARRES2 is linked to chronic kidney disease.